Shares of genetic testing company Myriad Genetics (NASDAQ:MYGN) jumped 2.5% in the afternoon session after the company announced it would present new data from eight studies at the 2025 San Antonio ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback